StockData
Ultralife Corp logo

Ultralife Corp (ULBI) stock

ULBINasdaqMiscellaneous Electrical Machinery, Equipment & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30102% above fair value
$15.68−0.05 (-0.32%)

Close on Nov 16, 2026Market cap $261.28MP/E –Yield –

Ultralife r&d expenses

Research and development expenses are spending on new products and technology.

Ultralife's R&D Expenses for the twelve months ending Jun 30, 2026 was $11.86M, up 28.4% year over year. For fiscal 2025 it was $10.40M, up 25.8% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $10.40M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.40M+25.8%
FY2024Dec 31, 2024$8.27M+9.8%
FY2023Dec 31, 2023$7.53M+6.4%
FY2022Dec 31, 2022$7.08M+3.7%
FY2021Dec 31, 2021$6.83M+14.8%
FY2020Dec 31, 2020$5.95M-12.6%
FY2019Dec 31, 2019$6.81M+51.0%
FY2018Dec 31, 2018$4.51M-4.8%
FY2017Dec 31, 2017$4.74M-20.3%
FY2016Dec 31, 2016$5.95M+6.1%
FY2015Dec 31, 2015$5.60M+5.1%
FY2014Dec 31, 2014$5.33M-9.0%
FY2013Dec 31, 2013$5.86M-18.8%
FY2012Dec 31, 2012$7.22M-16.0%
FY2011Dec 31, 2011$8.59M-1.9%
FY2010Dec 31, 2010$8.76M-7.4%
FY2009Dec 31, 2009$9.45M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.23M+39.1%
Q1 FY2026Mar 31, 2026$2.96M+23.2%
Q4 FY2025Dec 31, 2025$2.82M+16.9%
Q3 FY2025Sep 30, 2025$2.86M+35.9%
Q2 FY2025Jun 30, 2025$2.32M+16.1%
Q1 FY2025Mar 31, 2025$2.40M+36.9%
Q4 FY2024Dec 31, 2024$2.41M+30.3%
Q3 FY2024Sep 30, 2024$2.10M+12.4%
Q2 FY2024Jun 30, 2024$2.00M+12.3%
Q1 FY2024Mar 31, 2024$1.76M-13.6%
Q4 FY2023Dec 31, 2023$1.85M+11.8%
Q3 FY2023Sep 30, 2023$1.87M-1.4%
Q2 FY2023Jun 30, 2023$1.78M+6.3%
Q1 FY2023Mar 31, 2023$2.03M+9.4%
Q4 FY2022Dec 31, 2022$1.66M+3.3%
Q3 FY2022Sep 30, 2022$1.90M+10.0%
Q2 FY2022Jun 30, 2022$1.67M-9.8%
Q1 FY2022Mar 31, 2022$1.86M+12.8%
Q4 FY2021Dec 31, 2021$1.60M+5.6%
Q3 FY2021Sep 30, 2021$1.72M+7.3%
Q2 FY2021Jun 30, 2021$1.85M+45.3%
Q1 FY2021Mar 31, 2021$1.65M+6.4%
Q4 FY2020Dec 31, 2020$1.52M-29.5%
Q3 FY2020Sep 30, 2020$1.61M-20.8%
Q2 FY2020Jun 30, 2020$1.28M-19.7%
Q1 FY2020Mar 31, 2020$1.55M+49.4%
Q4 FY2019Dec 31, 2019$2.15M+97.3%
Q3 FY2019Sep 29, 2019$2.03M+84.6%
Q2 FY2019Jun 30, 2019$1.59M+30.3%
Q1 FY2019Mar 31, 2019$1.04M-5.9%
Q4 FY2018Dec 31, 2018$1.09M+3.0%
Q3 FY2018Sep 30, 2018$1.10M-18.9%
Q2 FY2018Jul 1, 2018$1.22M+2.8%
Q1 FY2018Apr 1, 2018$1.10M-3.3%
Q4 FY2017Dec 31, 2017$1.06M-29.8%
Q3 FY2017Oct 1, 2017$1.36M-0.1%
Q2 FY2017Jul 2, 2017$1.19M–
Q1 FY2017Apr 2, 2017$1.14M–
Q4 FY2016Dec 31, 2016$1.51M–
Q3 FY2016Sep 25, 2016$1.36M–

More Ultralife figures

See a number that looks wrong?